Lyra Therapeutics's market cap is currently $13.47M. The company's EPS TTM is $-1.532; its P/E ratio is ―; Lyra Therapeutics is scheduled to report earnings on March 5, 2025, and the estimated EPS forecast is $-0.12. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 1.56M	$ 1.36M	$ 285.00K	$ 0.00	$ 0.00
Gross Profit	$ 1.56M	$ 296.00K	$ -716.00K	$ -95.00K	$ -27.00K
Operating Income	$ -67.12M	$ -56.31M	$ -43.62M	$ -22.21M	$ -16.52M
EBITDA	$ -65.25M	$ -53.92M	$ -42.61M	$ -22.11M	$ -16.49M
Net Income	$ -62.68M	$ -55.28M	$ -42.41M	$ -22.05M	$ -16.09M
Balance Sheet
Cash & Short-Term Investments	$ 102.75M	$ 97.89M	$ 45.75M	$ 74.59M	$ 9.81M
Total Assets	$ 142.60M	$ 109.97M	$ 54.87M	$ 80.83M	$ 14.96M
Total Debt	$ 26.88M	$ 2.22M	$ 1.45M	$ 2.44M	$ 3.33M
Net Debt	$ 4.53M	$ -30.33M	$ -44.29M	$ -72.15M	$ -6.48M
Total Liabilities	$ 53.18M	$ 29.21M	$ 20.55M	$ 6.34M	$ 7.63M
Stockholders' Equity	$ 89.42M	$ 80.75M	$ 34.32M	$ 74.49M	$ 7.33M
Cash Flow
Free Cash Flow	$ -64.35M	$ -43.55M	$ -29.20M	$ -22.92M	$ -13.96M
Operating Cash Flow	$ -63.30M	$ -43.38M	$ -25.82M	$ -21.14M	$ -13.75M
Investing Cash Flow	$ -12.58M	$ -65.01M	$ -3.38M	$ -1.77M	$ -211.00K
Financing Cash Flow	$ 65.69M	$ 96.26M	$ 359.00K	$ 87.70M	$ -115.00K

Currency in USD

Lyra Therapeutics Earnings and Revenue History

Income Statement >

Lyra Therapeutics Debt to Assets

Balance Sheet >

Lyra Therapeutics Cash Flow

Cash Flow >

Lyra Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing